Page last updated: 2024-10-26

diphenyleneiodonium and Carcinoma

diphenyleneiodonium has been researched along with Carcinoma in 2 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, J1
Hu, C1
Zhu, Y1
Sun, R1
Fang, Y1
Fan, Y1
Xu, F1
Groth, S1
Schulze, M1
Kalthoff, H1
Fändrich, F1
Ungefroren, H1

Other Studies

2 other studies available for diphenyleneiodonium and Carcinoma

ArticleYear
LMP1 Increases Expression of NADPH Oxidase (NOX) and Its Regulatory Subunit p22 in NP69 Nasopharyngeal Cells and Makes Them Sensitive to a Treatment by a NOX Inhibitor.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Carcinoma; Cell Line; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Enzyme Inhib

2015
Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase.
    The Journal of biological chemistry, 2005, Sep-30, Volume: 280, Issue:39

    Topics: Biglycan; Carcinoma; Cell Adhesion; Cell Line, Tumor; Cytochalasin D; Enzyme Activation; Enzyme Inhi

2005